Jia Qian-Tao, Xu Li-Hui, Li Feng-Yao, Zha Qing-Bing, He Xian-Hui
Institute of Tissue Transplantation and Immunology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Sheng Wu Gong Cheng Xue Bao. 2007 Mar;23(2):284-91. doi: 10.1016/s1872-2075(07)60025-9.
HLA-A* 2402 is one of the most frequently encountered HLA-A alleles in East Asian populations. In order to study the CD8+ T cell responses in Chinese populations, we have described the generation and functional test of HLA-A* 2402 tetramer loaded with HCMV pp65(341-349) peptide (QYDPVAALF, QYD). The cDNA of HLA-A* 2402 heavy chain was cloned by RT-PCR from one of the donors. DNA fragment encoding the ectodomain of HLA-A* 2402 heavy chain fused at its carboxyl-terminal a BirA substrate peptide (BSP) was amplified by PCR with the cloned heavy chain cDNA as a template. The wild-type gene of HLA-A* 2402-BSP was not expressed in Escherichia coli (E. coli), while mutant HLA-A* 2402-BSP gene with optimized codons was overexpressed as inclusion bodies in E. coli. Furthermore, the soluble HLA-A* 2402-QYD monomers were generated by in vitro refolding of washed inclusion bodies in the presence of beta2-microglobulin and QYD peptide. The tetramer was subsequently formed by mixing HLA-A* 2402-QYD monomers with streptavidin-PE at a molar ratio of 4:1. Flow cytometry analysis indicated that this tetramer possessed binding activity with specific CTL from HLA-A24+ donors and the frequencies of tetramer-binding CTL were 0.09% - 0.37% within total CD8+ T cells. This tetrameric agent provides a powerful tool to explore the secrets of CTL responses against HCMV antigens in HLA-A* 2402 individuals.
HLA - A2402是东亚人群中最常见的HLA - A等位基因之一。为了研究中国人群中的CD8+T细胞反应,我们描述了负载人巨细胞病毒(HCMV)pp65(341 - 349)肽(QYDPVAALF,QYD)的HLA - A2402四聚体的产生及功能测试。通过逆转录聚合酶链反应(RT - PCR)从一名供体中克隆了HLA - A2402重链的cDNA。以克隆的重链cDNA为模板,通过聚合酶链反应(PCR)扩增编码HLA - A2402重链胞外结构域且在其羧基末端融合BirA底物肽(BSP)的DNA片段。HLA - A2402 - BSP的野生型基因在大肠杆菌(E. coli)中不表达,而密码子优化的突变型HLA - A2402 - BSP基因在大肠杆菌中以包涵体形式过量表达。此外,在β2 - 微球蛋白和QYD肽存在的情况下,通过对洗涤后的包涵体进行体外重折叠产生了可溶性HLA - A2402 - QYD单体。随后,将HLA - A2402 - QYD单体与链霉亲和素 - 藻红蛋白(streptavidin - PE)以4∶1的摩尔比混合形成四聚体。流式细胞术分析表明,该四聚体与来自HLA - A24+供体的特异性细胞毒性T淋巴细胞(CTL)具有结合活性,并且在总CD8+T细胞中四聚体结合CTL的频率为0.09% - 0.37%。这种四聚体试剂为探索HLA - A*2402个体中针对HCMV抗原的CTL反应奥秘提供了一个有力工具。